Phoenix Holdings Ltd. Spring Works Therapeutics, Inc. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$24.1 - $39.66 $9.96 Million - $16.4 Million	-413,423 Reduced 45.79%	489,444 $13.3 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $9.26 Million - $30.3 Million	504,221 Added 126.48%	902,867 $22.2 Million
Q1 2022 May 10, 2022	BUY	$48.97 - $65.46 $4.4 Million - $5.88 Million	89,890 Added 29.11%	398,646 $22.6 Million
Q4 2021 Feb 07, 2022	BUY	$53.3 - $75.84 $11.3 Million - $16 Million	211,141 Added 216.3%	308,756 $19.1 Million
Q3 2021 Oct 27, 2021	BUY	$62.66 - $88.26 $2.29 Million - $3.23 Million	36,615 Added 60.02%	97,615 $6.19 Million
Q2 2021 Aug 10, 2021	BUY	$67.45 - $85.63 $4.11 Million - $5.22 Million	61,000 New	61,000 $5.03 Million

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.